Designing live bacterial therapeutics for cancer
Advanced Drug Delivery Reviews · 2025-06 · 221 · 115579
DOI: 10.1016/j.addr.2025.115579 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-06. Verfasst von Jaehyun Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Neoplasms, Bacteria, Antineoplastic Agents. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 270 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Humans are home to a diverse community of bacteria, many of which form symbiotic relationships with their host. Notably, tumors can also harbor their own unique bacterial populations that can influence tumor growth and progression. These bacteria, which selectively colonize hypoxic and acidic tumor microenvironments, present a novel therapeutic strategy to combat cancer. Advancements in synthetic biology enable us to safely and efficiently program therapeutic drug production in bacteria, further enhancing their potential. This review provides a comprehensive guide to utilizing bacteria for cancer treatment. We discuss key considerations for selecting bacterial strains, emphasizing their colonization efficiency, the delicate balance between safety and anti-tumor efficacy, and the availability of tools for genetic engineering. We also delve into strategies for precise spatiotemporal control of drug delivery to minimize adverse effects and maximize therapeutic impact, exploring recent examples of engineered bacteria designed to combat tumors. Finally, we address the underlying challenges and future prospects of bacterial cancer therapy. This review underscores the versatility of bacterial therapies and outlines strategies to fully harness their potential in the fight against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, University of Chicago, Chicago, IL 60637, USA.
- Department of Microbiology, University of Chicago, Chicago, IL 60637, USA; Duchoissois Family Institute, University of Chicago, Chicago, IL 60637, USA; Committee On Molecular Metabolism and Nutrition, University of Chic…
- Department of Radiation and Cellular Oncology, University of Chicago, Chicago 60637, USA; The Ludwig Center for Metastasis Research, University of Chicago, Chicago 60637, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health National Institute of Allergy and Infectious Diseases
- National Institutes of Health National Cancer Institute
- National Institutes of Health
- NIH National Institute of General Medical Sciences
- Arnold and Mabel Beckman Foundation
Zitieren
APA
Lee, J., McClure, S., Weichselbaum, R. R., & Mimee, M. (2025). Designing live bacterial therapeutics for cancer. Advanced Drug Delivery Reviews, 221, 115579. https://doi.org/10.1016/j.addr.2025.115579
Vancouver
Lee J, McClure S, Weichselbaum RR, Mimee M. Designing live bacterial therapeutics for cancer. Advanced Drug Delivery Reviews. 2025;221:115579. doi:10.1016/j.addr.2025.115579
BibTeX
@article{Lee2025,
author = {Lee, Jaehyun and McClure, Sandra and Weichselbaum, Ralph R and Mimee, Mark},
title = {Designing live bacterial therapeutics for cancer},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {221},
pages = {115579},
doi = {10.1016/j.addr.2025.115579}
}
EUVIMED